Group One Trading
ENTX icon

Group One Trading’s Entera Bio ENTX Stock Holding History

Group One Trading’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,300
Closed -$9K – 8192
2021
Q4 		$9K Sell
3,300
-200
-6% -$749 ﹤0.01% 7391
2021
Q3 		$16K Sell
3,500
-600
-15% -$3.08K ﹤0.01% 7288
2021
Q2 		$25K Buy
+4,100
New +$15.2K ﹤0.01% 7050

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Group One Trading's ENTX Position: Q1 2026 in Review

Group One Trading held its Entera Bio (ENTX) position steady in Q1 2026 at 51 shares worth $57. The position accounts for ﹤0.01% of the portfolio, ranked #7446.

Group One Trading first reported a position in ENTX in Q3 2023 and has held it in 11 quarters since. The position peaked at $250 in Q3 2023. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

  • Group One Trading held 51 shares of Entera Bio worth $57 as of Q1 2026.
  • Group One Trading left its Entera Bio share count unchanged in Q1 2026.
  • Entera Bio made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7446 holding.
  • Group One Trading first reported a position in Entera Bio in Q3 2023 and has held it in 11 quarters since.
  • Group One Trading's Entera Bio position peaked at $250 in Q3 2023.
  • 26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.